Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar;69(3):657-659.
doi: 10.1007/s10620-023-08221-8. Epub 2024 Jan 13.

Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies

Andreas Stallmach  1 , Philip C Grunert  2
Affiliations
Editorial

Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies

Andreas Stallmach et al. Dig Dis Sci. 2024 Mar.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Prevalence of fatigue and quality of life in patients with IBD in clinical remission. Among those in remission, one-third experience both normal quality of life and are free from fatigue, while two-thirds of patients encounter either fatigue, impaired quality of life, or both simultaneously. N = 91, QoL = quality of life. Clinical remission was defined as a partial Mayo Score < 2 for UC and Harvey–Bradshaw Index < 5 for CD. Fatigue was defined as > 21 points on the Fatigue Assessment Scale (FAS) and impaired quality of life was defined as IBDQ-32 Score < 180. Unpublished data, extracted from (5)
See this image and copyright information in PMC

References

    1. Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. The American Journal of Gastroenterology. 2015;110:1324–1338. doi: 10.1038/ajg.2015.233. - DOI - PubMed
    1. Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160:1570–1583. doi: 10.1053/j.gastro.2020.12.031. - DOI - PubMed
    1. Vega P, Huguet JM, Gomez E, Rubio S. IBD-PODCAST Spain: a close look at current daily clinical practice in IBD management. Dig Dis Sci. (Epub ahead of print). 10.1007/s10620-023-08220-9. - PMC - PubMed
    1. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality-of-life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. The American Journal of Gastroenterology. 1996;91:1571–1578. - PubMed
    1. Uhlir V, Stallmach A, Grunert PC. Fatigue in patients with inflammatory bowel disease-strongly influenced by depression and not identifiable through laboratory testing: a cross-sectional survey study. BMC Gastroenterology. 2023;23:288. doi: 10.1186/s12876-023-02906-0. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources